Fresenius medical care delivers continued operating income improvements in the second quarter of 2024

Organic revenue growth of +2.3% supported by both segments care delivery and care enablement operating income1 and operating income margin1 increase driven by care enablement additional fme25 savings of eur 57 million achieved and on track to reach the upper end of the full year savings target range further divestitures closed as execution of portfolio optimization program continues net financial debt and net leverage ratio further improved fy 2024 outlook confirmed bad homburg, germany , july 30, 2024 /prnewswire/ -- "in the second quarter, we further improved our financial performance while executing against our strategic plan and the company transformation. this quarter is another important proof point for the operational turnaround as we remain focused to deliver on our targets", said helen giza, chief executive officer of fresenius medical care ag.
FMS Ratings Summary
FMS Quant Ranking